Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV).

Calender A, Cordier M, Billaud M, Lenoir GM.

Int J Cancer. 1990 Oct 15;46(4):658-63.

PMID:
1698730
2.

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM.

J Virol. 1990 Mar;64(3):1002-13.

4.

Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.

Cordier-Bussat M, Billaud M, Calender A, Lenoir GM.

Int J Cancer. 1993 Jan 2;53(1):153-60.

PMID:
8416201
5.
7.

Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.

Calender A, Billaud M, Aubry JP, Banchereau J, Vuillaume M, Lenoir GM.

Proc Natl Acad Sci U S A. 1987 Nov;84(22):8060-4.

8.
9.

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

Polack A, Hörtnagel K, Pajic A, Christoph B, Baier B, Falk M, Mautner J, Geltinger C, Bornkamm GW, Kempkes B.

Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10411-6.

10.

Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.

Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.

Int Immunol. 1992 Nov;4(11):1283-92.

PMID:
1282031
11.

Regulation of c-fgr proto-oncogene expression in Epstein-Barr virus infected B-cell lines.

Patel M, Leevers SJ, Brickell PM.

Int J Cancer. 1990 Feb 15;45(2):342-6.

PMID:
2154410
13.

Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells.

Pajic A, Staege MS, Dudziak D, Schuhmacher M, Spitkovsky D, Eissner G, Brielmeier M, Polack A, Bornkamm GW.

Int J Cancer. 2001 Sep;93(6):810-6.

15.

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14935-40. Epub 2006 Sep 25.

16.
17.

Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

Strobl LJ, Höfelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U.

J Virol. 2000 Feb;74(4):1727-35.

19.

Supplemental Content

Support Center